Healthy Living/WellnessFDA Rejects BioMarin Pharmaceutical's Duchenne Muscular Dystrophy Drug The FDA denied BioMarin's Duchenne muscular dystrophy drug drisapersen, branded as Kyndrisa. DMD is a genetic disease characterized by gradual muscle deterioration and weakness. The disease affects one in every 3,500 to 5,000 male children.by Katherine Derla
Business TechAlphabet Introduces Verily, The Health Division Formerly Known As Google Life Sciencesby Lauren Keating
Healthy Living/WellnessWomen More Likely To Become Addicted To Prescription Painkillers: Studyby Julienne Roman
Healthy Living/WellnessCytokinetics, Amgen Heart Failure Drug Shows Promise In Clinical Studyby Julienne Roman
Healthy Living/WellnessMany People Who Think They Are Allergic To Penicillin May Safely Take The Drug: Studyby Julienne Roman